ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAC0. A total of 9 filers reported holding ACORDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,266,250 | -2.5% | 25,875,000 | 0.0% | 1.51% | -2.3% |
| Q2 2023 | $15,654,375 | -2.4% | 25,875,000 | 0.0% | 1.54% | -34.9% |
| Q1 2023 | $16,042,500 | -2.4% | 25,875,000 | 0.0% | 2.37% | +30.1% |
| Q4 2022 | $16,430,625 | -15.3% | 25,875,000 | 0.0% | 1.82% | -4.4% |
| Q3 2022 | $19,404,000 | +2.0% | 25,875,000 | 0.0% | 1.90% | +26.3% |
| Q2 2022 | $19,021,000 | -4.3% | 25,875,000 | 0.0% | 1.51% | +104.9% |
| Q1 2022 | $19,875,000 | -0.6% | 25,875,000 | 0.0% | 0.74% | +8.2% |
| Q4 2021 | $19,988,000 | -3.4% | 25,875,000 | 0.0% | 0.68% | -6.6% |
| Q3 2021 | $20,700,000 | +8.8% | 25,875,000 | 0.0% | 0.73% | +3.1% |
| Q2 2021 | $19,018,000 | -6.1% | 25,875,000 | -5.5% | 0.71% | -12.1% |
| Q1 2021 | $20,244,000 | – | 27,375,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 25,875,000 | $19,021,000 | 1.51% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 45,283,000 | $34,415,000 | 0.78% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 52,324,000 | $38,202,000 | 0.66% |
| UBS OCONNOR LLC | 30,000,000 | $22,523,000,000 | 0.33% |
| Soros Fund Management | 28,001,000 | $16,213,000 | 0.29% |
| Saltoro Capital, LP | 1,500,000 | $1,110,000 | 0.27% |
| D. E. Shaw & Co., Inc. | 14,000,000 | $10,435,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 5,018,000 | $3,814,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |